News

Find News

Filter articles

Showing 21 to 30 of 3435 results

Former FDA chief counsel joins Morrison & Foerster's DC office

US22-09-2021Alex Baldwin

Former Food and Drug Administration Chief Counsel Stacy Cline Amin has been hired as a partner at Morrison & Foerster’s life sciences and healthcare practice in Washington DC.

Zoetis sues rival over generic pet vomiting treatment

US21-09-2021Alex Baldwin

Veterinary drug maker Dechra’s generic of a drug that treats vomiting in dogs and cats, Cerenia, infringes a patent owned by its competitor Zoetis, a new lawsuit has alleged.

Lawmakers urge USPTO to curb IPR denials under Fintiv

US21-09-2021Alex Baldwin

Several US lawmakers have called upon the US Patent and Trademark Office to curb the increase in inter partes review denials to combat the “soaring cost” of prescription drugs.

Supernus hits Zydus with repeat suit over migraine drug

US20-09-2021Muireann Bolger

Supernus Pharmaceuticals has once again accused Indian generic drugmaker Zydus Cadila and its US unit of allegedly infringing 10 patents with its copycat of Trokendi XR (topiramate), a drug for migraines and seizures.

WHO plans to vaccinate Africa with Moderna COVID vaccine hit stumbling block

Africa16-09-2021Ben Wodecki

Just 12 African countries have hit WHO’s 10% vaccination target as supply chain issues worsen.

Intel backs Mylan's anti-Fintiv SCOTUS stance

US16-09-2021Muireann Bolger

Intel has backed Mylan's bid to convince the US Supreme Court to remove the controversial NHK-Fintiv rule, on the basis that it is “unlawful”.

Allergan closes the book on Fetzima generics suit

US16-09-2021Alex Baldwin

Allergan has struck a deal with two generic manufacturers to resolve a long-running patent infringement suit over its antidepressant drug Fetzima.

FDA urges USPTO to tackle rising drug costs

US14-09-2021Muireann Bolger

The US Food and Drug Administration has urged the US Patent and Trademark Office (USPTO) to curb drug costs in the wake of President Joe Biden’s plan to promote competition in the pharmaceutical sector.

Bausch settles $300m antitrust case over diabetes drug price hikes

US13-09-2021Ben Wodecki

Canadian pharma firm Bausch Health has agreed to settle an antitrust suit where it was accused of holding an illegal monopoly on the diabetes drug Glumetza.

Pfizer to settle Xeljanz suit with Teva

US09-09-2021Alex Baldwin

Pfizer has asked a Delaware court to drop an infringement lawsuit against Teva Pharmaceuticals over a proposed generic of its rheumatoid arthritis drug Xeljanz.

Showing 21 to 30 of 3435 results

LSIPR